TRIM33 and myositis disease: From the UK JDM myositis cohort, 55 (14%) were anti-TIF1γ positive, 79% White, 58% Female, median age at onset (IQR) 6.9 (3.8–10.1) years (Supplementary Table S1B, available at Rheumatology online).